Crossmark Global Holdings Inc. Has $33.45 Million Position in Cigna Group $CI

Crossmark Global Holdings Inc. decreased its holdings in Cigna Group (NYSE:CI) by 3.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 116,050 shares of the health services provider’s stock after selling 4,687 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Cigna Group were worth $33,451,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in CI. Harbor Capital Advisors Inc. raised its position in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares in the last quarter. Collier Financial acquired a new position in shares of Cigna Group in the 3rd quarter worth approximately $34,000. NewSquare Capital LLC raised its holdings in shares of Cigna Group by 38.8% in the 2nd quarter. NewSquare Capital LLC now owns 143 shares of the health services provider’s stock worth $47,000 after buying an additional 40 shares in the last quarter. Traub Capital Management LLC acquired a new position in Cigna Group during the second quarter worth $48,000. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in shares of Cigna Group in the 2nd quarter worth about $52,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CI. Leerink Partners lifted their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. UBS Group restated a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Robert W. Baird cut their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $330.42.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna’s credit ratings were affirmed by AM Best (Financial Strength Rating A / Long‑Term ICR “a+”), which reduces balance‑sheet and counterparty concerns for investors. AM Best affirms ratings
• Positive Sentiment: Major sell‑side support remains: Piper Sandler kept an Overweight stance and high price target (small trim), and other analysts continue to highlight Cigna’s growth profile after strong earnings. That provides continued analyst backing for the stock. Piper Sandler price target story
• Positive Sentiment: Cigna reaffirmed its 2026 financial outlook while announcing the CEO succession and elected Brian Evanko to the board — the outlook reaffirmation reduces immediate guidance risk. PR Newswire release
• Positive Sentiment: Cigna raised its quarterly dividend (announced recently), which supports income investors and signals management confidence in cash flow. MarketBeat dividend note
• Neutral Sentiment: Management appearances and investor conference activity (TD Cowen) plus regional PR (awards, interviews) provide investor color but are not immediate stock catalysts. TD Cowen presentation notice
• Neutral Sentiment: Profile/interview pieces on outgoing CEO David Cordani and the company’s long-term strategy add context for investors but are informational rather than catalytic. Courant CEO profile
• Negative Sentiment: The CEO succession (David Cordani to retire July 1; President/COO Brian Evanko to succeed) prompted an initial negative market reaction as investors digested leadership change and execution risk, which was the primary near‑term drag on the stock. Seeking Alpha on leadership transition
• Negative Sentiment: Insider selling (recent filings show officers/directors trimming positions) can amplify near‑term downward pressure or signal liquidity needs; monitor whether sales continue. InsiderTrades alert
• Negative Sentiment: Broader healthcare sector weakness this week is a headwind for CI — sector declines can depress even well‑funded insurers in the short term. Yahoo sector update

Cigna Group Stock Up 0.2%

Shares of CI opened at $284.50 on Thursday. The business’s fifty day moving average price is $280.68 and its two-hundred day moving average price is $284.45. The firm has a market capitalization of $74.97 billion, a price-to-earnings ratio of 12.83, a PEG ratio of 0.98 and a beta of 0.27. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is presently 27.23%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.